MICHELLE JEWELL: Open Payments
NPI 1902189491 · MAYFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 19 payments from 9 companies in 2025. Trend: 2023 $436 · 2024 $633 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Lilly USA, LLC | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $15 |
Products named: MOUNJARO, FARXIGA, AIRSUPRA, REXULTI, Dexcom G6 Transmitter, Auvelity, CAPLYTA, VRAYLAR.
Industry payments across KY — which companies pay providers there.
